Drug Metabolism and Pharmacokinetics 2020
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: closed (30 November 2020) | Viewed by 4130
Special Issue Editor
Interests: clinical trials; new drug development; drug/drug(food) interaction; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Drug metabolism and pharmacokinetics covers all aspects of pre-clinical and clinical pharmacokinetics and pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, CYP pharmacogenetics, PK/PD relationship, bioavailability and bioequivalence, drug–drug interactions, as well as clinical pharmacokinetics in older adults and children. Other topics such as clinical pharmacokinetics in certain disease states such as hepatic, renal, or thyroid disease; individual drug metabolism and pharmacokinetics; analytical method development and validation for drug metabolism and pharmacokinetic studies will also be included.
In the coming years, the onset of a revolutionary transformation of protocols and strategies for drug development is expected. Accurate information for pharmacokinetics and metabolism is one of the key factors to entering the complex arena of personalized medicine.
I would like to invite all of you, experts and beginners in the field of drug metabolism and pharmacokinetics, to contribute to this Special Issue with your ideas for accelerating the implementation of drug metabolism and pharmacokinetics research in drug development, as well as in clinical trials and clinical practice.
This Special Issue will publish original research articles, review articles, leading articles, and current opinion articles on the topics discussed above.
All manuscripts are subject to peer review by international experts.
Prof. Dr. Ju-Seop Kang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug disposition, metabolism, transport and interactions
- therapeutic drug monitoring
- CYP pharmacogenetics
- PK/PD relationship
- toxicokinetics and toxicodynamics
- bioavailability and bioequivalence
- drug-drug/ drug-food interactions
- clinical pharmacokinetics in older adults and children
- clinical pharmacokinetics in certain disease such as hepatic, renal or thyroid disease
- individual drug metabolism and pharmacokinetics
- analytical method development and validation for drug metabolism and pharmacokinetic studies
